Start Date
July 15, 2017
Primary Completion Date
July 17, 2018
Study Completion Date
July 17, 2018
PRIM-DJ2727
Thirty eligible subjects with PD will be randomly assigned to receive either PRIM-DJ2727 in orally administered enteric-coated capsules or placebo capsules
Placebo (for PRIM-DJ2727)
Thirty eligible subjects with PD will be randomly assigned to receive placebo capsules
Collaborators (1)
Kelsey Research Foundation
OTHER
The University of Texas Health Science Center, Houston
OTHER